Breed Reply Invests in METRON and TAG Sensors
The two companies raised a total of £3.75 million from Breed Reply and other investors. These new investments mean Breed Reply’s pan-European investment portfolio of early stage IoT businesses has increased to 20 in a variety of different sectors, including health, industrial IoT, smart buildings and cities, and transportation.
METRON increases Breed Reply’s focus on industrial IoT technology. Energy is a significant cost in many industries and METRON’s technology provides industrial clients with an intelligent network that can better manage energy usage.
The technology provides the virtual mapping of the energy used in industrial processes and big data analytics to allow companies to be predictive and proactive in energy efficiency. By using artificial intelligence and control capabilities, METRON’s platform communicates directly with energy markets and decentralized energy assets to optimise operations in real-time according to context. Its customers include leading manufacturing companies from a variety of energy-intensive industries and METRON also partners with facility managers, utilities and OEMs in Europe, Latin America and the Middle-East.
TAG Sensors platform also offers significant benefits to customers, particularly in the pharmaceutical and food industries, including McDonald’s, where temperature control of goods is vital to ensure product quality. TAG Sensors has developed a market-leading technology using radio-frequency identification (RFID). For the first time, it is possible to have continuous real-time temperature logging of individual products required to be kept at specific temperatures such as food and vaccines. In the food industry, an estimated $813 billion is lost each year globally from poor cold-chain management and the pharmaceutical industry loses an estimated $12.5 billion per annum due to temperature fluctuations of products in shipping and storage.
Both METRON and TAG Sensors meet Breed Reply’s investment criteria of companies that combine strong management teams with an innovative technology that solves a real-world problem.
As well as funding, Breed Reply will work closely with management to accelerate both companies’ development to achieve Series A funding and beyond. Last year, one-third of Breed Reply’s portfolio raised more than $50 million of Series A funding.
The Breed Reply team has significant experience in scaling up early-stage businesses, in-depth understanding of different markets, proven track record in sales channel development and strong technological DNA. They also work closely with Reply Group, a leading consulting, systems integration and digital services company with a market presence all over Europe and the USA to help the investee companies commercialise their products.
Emanuele Angelidis, CEO of Breed Reply, said: “METRON and TAG Sensors are fantastic additions to our investment portfolio. As well as strong management, they have business ideas with long-term potential and technologies that companies are looking for. There is a considerable market for TAG Sensors low cost, versatile and highly-automated solution to the problem of cold-chain management and METRON’s ability to deliver improved energy efficiency to lower costs and meet ever stricter environmental regulations is vital for a multitude of industries. We are looking forward to supporting them to achieve their ambitions.”
Vincent Sciandra, CEO, METRON said: “This new funding will support the international growth of METRON and increase our ability to roll-out our highly successful energy intelligence platform. Over the last five years, we have helped companies across a variety of industries turn energy efficiency from a static, reactive process into a dynamic, proactive strategy. We are reshaping the way energy data is used. It is a strong endorsement of our technology and potential that Breed Reply has backed us and we look forward to working with them.”
Knut Nygard, CEO, TAG Sensors, said: “There is increasing global demand for our complete solution for cold chain management from leading companies in both the pharmaceutical and food industries. Major brands such as McDonald’s have tested and adopted our system in recent years and this new funding will enable us to expand and make our system available to more and more customers. The addition of Breed Reply as an investor, with its expertise in helping IoT companies scale-up and continued support of Platform Ventures will help us grow, invest more in innovation and seek opportunities in other sensor-based market segments.”
About Breed Reply
Breed Reply, Reply's active operational investor, funds and supports the development of early-stage companies in the Internet of Things (IoT) in Europe and the USA. Based in London, with operational offices in Germany and Italy, Breed Reply supports entrepreneurs and young talent by quickly bringing new ideas to the market. This is done via three fundamental services: funding at early-stage level; active operational involvement with significant know how transfer of business, managerial and technological expertise; and go-to-market support through the extensive Reply network. Breed Reply’s focus is the Internet of Things over all markets, with their current portfolio in Health, Fitness & Wellness, Smart Building & Cities, Security, Industrial IoT, Big Data, Platforms and Drones.www.breedreply.com
Founded in 2013, METRON has developed an energy intelligence platform to help industrial factories become energy transparent. By harnessing multiple sources of data generated by industrial systems, METRON Energy Virtual Assistant leverages latest machine learning capabilities and dedicated knowledge bases to proactively identify energy savings opportunities, connect to decentralised energy resources and turn energy into a profit centre. The company has more than 40 experts, data scientists and energy engineers, who help industrial clients in all sectors to maximise value from their energy data and support them with the implementation of energy efficiency optimisations.
About TAG Sensors
TAG Sensors is a complete cold-chain logistics solution for the food and pharmaceutical industries. It has developed the first low-cost, full visibility solution that ensures and proves that temperature sensitive foods and pharmaceutical products have been stored and transported within the temperature limits.
TAG Sensors radio-frequency identification (RFID) temperature logger label is the only one on the market that can effectively track temperature and other variables of an individual package from production to consumption, ensuring transparency, improving quality control and minimising wastage due to improper handling.
Redleaf Communications for Breed Reply
Robin Tozer / Ian Silvera
+44 (0)20 3757 6865
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
AURAK Gains SACSCOC Accreditation15.12.2018 13:49 | Tiedote
The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now
Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 20:41 | Tiedote
Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 20:00 | Tiedote
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 18:42 | Tiedote
Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 17:00 | Tiedote
Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07 | Tiedote
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme